ABDUSSAMI HADI: Open Payments
NPI 1649413709 · LEVITTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$471 in 25 payments from 10 companies in 2025. Trend: 2023 $833 · 2024 $460 · 2025 $471
Food & beverage: $471
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $220 |
| Indivior Inc. | 3 | $73 |
| Cumberland Pharmaceuticals, Inc. | 1 | $40 |
| Orexo US, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $23 |
| Forte Bio-Pharma LLC | 1 | $22 |
| SCILEX PHARMACEUTICALS INC. | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Belbuca, SUBLOCADE, KRISTALOSE, Zubsolv, UBRELVY, TANLOR, XTAMPZA, ZTLido.
Industry payments across NY — which companies pay providers there.
